TXA, which blocks lysine-dependent plasmin generation and inhibits the dissolution and degradation of fibrin clots, can alter the delicate balance between coagulation and fibrinolysis and theoretically have detrimental implications for outcomes, resulting in vascular occlusive events, pulmonary embolism, and deep vein thrombosis [43]. Here, PLG is linked to deep vein thrombosis.